| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease (NCT00001101) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients (NCT00001116) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Prevention of Kidney Transplant Rejection (NCT00005010) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs (NCT00001103) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects (NCT00001053) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects (NCT00000795) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus (NCT00000683) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy (NCT00000677) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease (NCT00000880) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible (NCT00000939) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection (NCT00000750) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients (NCT00000896) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children (NCT00000761) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine (NCT00000838) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00001013) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials (NCT00075062) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV (NCT00016783) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00000655) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes (NCT00001062) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma (NCT00000769) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy (NCT00000909) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants (NCT00000878) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia (NCT00000724) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents (NCT00091702) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Influenza Immunity Against Pandemic Respiratory Virus (NCT00138281) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection (NCT00000716) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss (NCT00001079) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo) (NCT00000777) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT (NCT00000653) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Long-Term Effects of HIV Exposure and Infection in Children (NCT00006304) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients (NCT00000947) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328 (NCT00000943) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns (NCT00000920) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years (NCT00006509) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies (NCT00000714) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers (NCT00000879) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC) (NCT00000701) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 (NCT00000949) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| RCT ALB for SA Cysticercosis (NCT00133458) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia (NCT00000974) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure (NCT00000918) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women (NCT00096694) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers (NCT00062530) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects (NCT00000792) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children (NCT00000811) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group (NCT00000815) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children (NCT00000967) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure (NCT01049633) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants (NCT00001135) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses (NCT00001108) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes (NCT00001005) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth (NCT00001007) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials (NCT00000759) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose (NCT00001056) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies (NCT00006075) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine (NCT00000706) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV (NCT00084032) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 (NCT00000933) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) (NCT00001046) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients (NCT00000953) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Methadone Effects on Zidovudine (ZDV, AZT) Disposition (NCT00000800) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults (NCT00027261) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV (NCT00001034) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 (NCT00000738) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection (NCT00013520) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides (NCT00001028) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children (NCT00000849) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer (NCT00000723) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS (NCT00001061) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160 (NCT00000757) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma (NCT00000801) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Anti-HIV Treatment Plans (NCT00005915) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment (NCT00000902) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) (NCT00001126) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS (NCT00000640) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive (NCT00000721) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Observing Patients With Early HIV Infection (NCT00005020) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| CMV Retinitis Retreatment Trial (NCT00000766) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Adding New Drugs for HIV Infected Patients Failing Current Therapy (NCT00031044) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection (NCT00015652) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma (NCT00000994) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection (NCT00050284) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 (NCT00000625) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma (NCT00000689) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Disease Progression and Anti-HIV Treatments (NCT00001068) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV (NCT00027365) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children (NCT00000634) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers (NCT00000832) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults (NCT00614640) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies (NCT00000910) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00001113) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients (NCT00001074) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Methotrexate for HIV Infection (NCT00000834) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC. (NCT00000704) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador (NCT00279331) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients (NCT00000730) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants (NCT00000873) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children (NCT00001066) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes (NCT00001012) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium (NCT00001081) | National Institute of Allergy and Infectious Diseases (NIAID) | |